相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Christopher Southan et al.
NUCLEIC ACIDS RESEARCH (2016)
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
Astrid W. Oosten et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Overview
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Pharmacokinetic Interaction of Intravenous Fentanyl With Ketoconazole
Victoria C. Ziesenitz et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures
Astrid W. Oosten et al.
JOURNAL OF PAIN (2015)
Determining the optimal dose in the development of anticancer agents
Ron H. J. Mathijssen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
Daniel T. Barratt et al.
PHARMACOGENETICS AND GENOMICS (2014)
Impact of CYP3A5*3 on Plasma Exposure and Urinary Excretion of Fentanyl and Norfentanyl in the Early Postsurgical Period
Noriaki Tanaka et al.
THERAPEUTIC DRUG MONITORING (2014)
Fentanyl Pharmacokinetics is not Dependent on Hepatic Uptake by Organic Anion-Transporting Polypeptide 1B1 in Human Beings
Victoria C. Ziesenitz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Pharmacokinetics and Dose Proportionality of Fentanyl Sublingual Spray: a Single-Dose 5-Way Crossover Study
Neha Parikh et al.
CLINICAL DRUG INVESTIGATION (2013)
Serum Concentration of Fentanyl During Conversion From Intravenous to Transdermal Administration to Patients With Chronic Cancer Pain
Motoo Nomura et al.
CLINICAL JOURNAL OF PAIN (2013)
Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl
Michael Perelman et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Impact of CYP3A5 and ABCB1 Gene Polymorphisms on Fentanyl Pharmacokinetics and Clinical Responses in Cancer Patients Undergoing Conversion to a Transdermal System
Yoshiaki Takashina et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Randomized 5-Treatment Crossover Study to Assess the Effects of External Heat on Serum Fentanyl Concentrations During Treatment With Transdermal Fentanyl Systems
Kenneth T. Moore et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pharmacological and clinical aspects of immediate release fentanyl preparations: criteria for selection
E. J. M. Kuip et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE (2012)
Epidemiology and Pattern of Care of Breakthrough Cancer Pain in a Longitudinal Sample of Cancer Patients Results From the Cancer Pain Outcome Research Study Group
Maria Teresa Greco et al.
CLINICAL JOURNAL OF PAIN (2011)
The Population Pharmacokinetics of Fentanyl in Patients Undergoing Living-Donor Liver Transplantation
S-J Jin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Fentanyl for breakthrough pain: a systematic review
Mellar P. Davis
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Absorption and tolerability of fentanyl buccal soluble film (FBSF) in patients with cancer in the presence of oral mucositis
Andrew Finn
Journal of Pain Research (2011)
Formulations of Fentanyl for the Management of Pain
Sina Grape et al.
DRUGS (2010)
Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction
Tomer T. Levin et al.
GENERAL HOSPITAL PSYCHIATRY (2010)
Fentanyl Transdermal Absorption Linked to Pharmacokinetic Characteristics in Patients Undergoing Palliative Care
Nadine F. J. Van Nimmen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Opioid-Induced Respiratory Depression Resulting from Transdermal Fentanyl-Clarithromycin Drug Interaction in a Patient with Advanced COPD
Robert Horton et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Transdermal fentanyl in cachectic cancer patients
Tarja Heiskanen et al.
PAIN (2009)
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl
Teijo I. Saari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Fentanyl clearance and volume of distribution are increased in patients with major burns
Taehyung Han et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis - A pilot study
Mona Darwish et al.
CLINICAL DRUG INVESTIGATION (2007)
Possible fluconazole-fentanyl interaction - a case report
Par Hallberg et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients
I Solassol et al.
THERAPEUTIC DRUG MONITORING (2005)
Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate
ED Kharasch et al.
ANESTHESIOLOGY (2004)
Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate
ED Kharasch et al.
ANESTHESIOLOGY (2004)
Support of the metabolic response to burn injury
DN Herndon et al.
LANCET (2004)
The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat
MA Ashburn et al.
JOURNAL OF PAIN (2003)
Simultaneous assessment of drug interactions with low- and high-extraction - Opioids application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil
AE Ibrahim et al.
ANESTHESIOLOGY (2003)
The influence of sex on pharmacokinetics
JB Schwartz
CLINICAL PHARMACOKINETICS (2003)
Itraconazole-fentanyl interaction in a cancer patient
S Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Population pharmacokinetics of fentanyl in healthy volunteers
RE Ariano et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Transdermal fentanyl - An updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control
RBR Muijsers et al.
DRUGS (2001)
Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system
TS Shomaker et al.
PAIN MEDICINE (2000)
Clinical pharmacokinetics of transdermal opioids - Focus on transdermal fentanyl
S Grond et al.
CLINICAL PHARMACOKINETICS (2000)